Production (Stage)
Medtronic plc
MDT
$89.92
$0.520.58%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 04/25/2025 | 01/24/2025 | 10/25/2024 | 07/26/2024 | 04/26/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.82% | 1.40% | 4.53% | 8.48% | -2.18% |
| Total Depreciation and Amortization | 2.38% | 0.11% | -2.29% | -2.37% | -1.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.42% | 109.84% | 32.95% | 63.34% | 72.05% |
| Change in Net Operating Assets | -117.77% | 31.76% | 71.01% | 45.63% | 49.95% |
| Cash from Operations | 3.79% | 12.72% | 29.17% | 18.30% | 12.39% |
| Capital Expenditure | -17.14% | -18.65% | -11.21% | -26.39% | -8.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 53.55% | -217.57% | -759.09% | 68.79% | 88.70% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 103.52% | 84.59% | 31.46% | 68.23% | -240.12% |
| Cash from Investing | 18.13% | 0.09% | -16.35% | 14.75% | 32.26% |
| Total Debt Issued | 199.07% | 38.41% | 0.34% | -36.00% | -86.05% |
| Total Debt Repaid | -- | 79.45% | 98.88% | 89.57% | -- |
| Issuance of Common Stock | 78.87% | 56.72% | 20.72% | -13.45% | -7.79% |
| Repurchase of Common Stock | -51.31% | -656.01% | -731.50% | -871.37% | -231.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.10% | 1.45% | 0.55% | -0.41% | -1.38% |
| Other Financing Activities | -6,033.33% | 177.40% | 68.53% | 98.55% | 99.27% |
| Cash from Financing | 2.00% | 22.98% | 32.71% | -3.75% | 10.28% |
| Foreign Exchange rate Adjustments | 181.74% | 36.48% | -92.46% | -149.08% | -194.65% |
| Miscellaneous Cash Flow Adjustments | -- | -200.00% | -100.00% | -- | -- |
| Net Change in Cash | 460.62% | 86.79% | 102.36% | 96.50% | 88.07% |